STIL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.05900000002546E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.569300E-04 |
Normal-vs-Stage2 |
2.292100E-02 |
Normal-vs-Stage3 |
6.29260000000187E-05 |
Normal-vs-Stage4 |
1.90830000001974E-06 |
Stage1-vs-Stage2 |
9.443800E-01 |
Stage1-vs-Stage3 |
3.107700E-02 |
Stage1-vs-Stage4 |
7.575900E-04 |
Stage2-vs-Stage3 |
8.322400E-02 |
Stage2-vs-Stage4 |
2.402200E-03 |
Stage3-vs-Stage4 |
8.660200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.3771999997696E-07 |
Normal-vs-AfricanAmerican |
1.014800E-01 |
Normal-vs-Asian |
6.101900E-02 |
Caucasian-vs-AfricanAmerican |
3.897500E-02 |
Caucasian-vs-Asian |
7.319600E-02 |
AfricanAmerican-vs-Asian |
1.186250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.5456999999941E-06 |
Normal-vs-Female |
7.84420000000674E-05 |
Male-vs-Female |
3.857200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.339800E-02 |
Normal-vs-Age(41-60Yrs) |
5.82459999999285E-05 |
Normal-vs-Age(61-80Yrs) |
3.33860000001351E-06 |
Normal-vs-Age(81-100Yrs) |
2.023000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.579800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.929400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.441600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.724000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.010300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.101900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.365630E-01 |
Normal-vs-Grade 2 |
5.227500E-04 |
Normal-vs-Grade 3 |
4.03390000000003E-05 |
Normal-vs-Grade 4 |
2.79520000001643E-06 |
Grade 1-vs-Grade 2 |
2.912200E-01 |
Grade 1-vs-Grade 3 |
5.005700E-02 |
Grade 1-vs-Grade 4 |
3.594000E-04 |
Grade 2-vs-Grade 3 |
1.093380E-01 |
Grade 2-vs-Grade 4 |
7.839500E-04 |
Grade 3-vs-Grade 4 |
7.576800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.979800E-03 |
Normal-vs-ccB subtype |
3.54840000049705E-07 |
ccA subtype-vs-ccB subtype |
3.984900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.53972999999974E-05 |
Normal-vs-N1 |
3.764900E-03 |
N0-vs-N1 |
2.775900E-02 |
|
|